Please login to the form below

Not currently logged in
Email:
Password:

Pharma profit

This page shows the latest Pharma profit news and features for those working in and with pharma, biotech and healthcare.

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

The size and significance of the $74bn acquisition of Celgene by Bristol-Myers Squibb announced last week has sparked much debate, about its implications for pharma, and what it says about ... big pharma companies.

Latest news

  • US insurers can peg access to ICER value reviews US insurers can peg access to ICER value reviews

    using prior authorisation for some medicines to make sure prescribing is in line with evidence-based rules, and encouraging competition between pharma companies for product placement on formularies. ... The new measures will lower costs for patients and

  • Inside the patient-centricity bubble Inside the patient-centricity bubble

    The hybrid model. However, ringing true to pharma, innovation comes at a price. ... Patients do  not want pharma not to make a profit, because they know the drug that can help them in the future  can only be made if there’s a profit.”

  • Gates’ non-profit biotech for poverty diseases sets out its stall at BIO Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

    The Bill &Melinda Gates Foundation’s new non-profit biotech - the Gates Medical Research Institute - had its first public outing at the BIO meeting last week. ... Think of [Gates MRI] as a non-profit biotech that is focused on the diseases of the

  • Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

    Like Trump, Azar had his own direct warning to pharma – but coming from an ex-pharma executive, the threats carried more of a sting. ... I’ve been a drug company executive – I know the tired talking points: the idea that if one penny disappears

  • Profit: the ugly, dirty truth? Profit: the ugly, dirty truth?

    There is no getting away from it. Outside Wall Street, profit is a sensitive and touchy subject for pharma companies. ... It seems easy to attack pharma companies for their profits, but no one should lose sight of the fact that profit is the fuel needed

More from news
Approximately 1 fully matching, plus 73 partially matching documents found.

Latest Intelligence

  • Trust me, I’m from pharma Trust me, I’m from pharma

    sceptical. There’s a sense among the wider public that pharma still puts profit before patients. ... Pharma shouldn’t need to be apologetic about making a profit – but it does need to explain why profit is important and what the industry does with

  • Proving real-world value Proving real-world value

    This enables pharma companies to give trusts something they can roll-out themselves - and everyone benefits from the data. ... There’s a growing evidence-base that pharma can harness to drive better outcomes.

  • Don't you forget about me Don't you forget about me

    obviously an area of significant focus for pharma as they continue to introduce innovative therapies. ... When it comes to best practice, not-for-profit organisations are really showing the pharma world what support can and should look like.

  • Listen? Do you want to know a secret? Listen? Do you want to know a secret?

    Social media listening is currently trending,  but is it ‘hear’ to stay for pharma? ... With public trust in pharma perennially questioned, the industry cannot afford insinuations of eavesdropping in the pursuit of profit.

  • Unravelling China’s healthcare sector Unravelling China’s healthcare sector

    However, leading companies are no longer satisfied with the increasing competition and diminishing profit margin. ... Jiangsu Hengrui Pharma and Hutchison Medi Pharma are running clinical trials in overseas regulated markets including the US .

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • New Merck Foundation appoints Rasha Kelej New Merck Foundation appoints Rasha Kelej

    She takes up role as CEO of the pharma firm's newly-established non-profit. ... Rasha Kelej has been appointed chief executive officer for Merck KGaA’s non-profit limited liability company, The Merck Foundation.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Don't you forget about me...

    obviously an area of significant focus for pharma as they continue to introduce innovative therapies. ... best practice, not-for-profit organisations are really showing the pharma world what support can and should look like.

  • GOOD PHARMA — Better for patients, better for business

    Pharma is a dirty word to some. Even to those with milder views, it’s an industry often painted with an unenviable public image. ... Indisputably, pharma companies are powered by profit, but so is any business.

  • HAVAS LYNX

    Today, smart pharma companies should be asking that same question about another major development: Connected Health. ... Indisputably, pharma companies are powered by profit, but so is any business.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics